Fetal Monitoring Market Size & Growth Forecast 2027–2036, By Segments (Method, End User, Product, Portability), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Fetal Monitoring Market size was worth USD 6.49 Billion in 2026 and is expected to grow at 7.21% CAGR between 2027 and 2036, reaching USD 13.02 Billion by 2036. The industry revenue for 2027 is calculated at USD 6.89 Billion.

• Base Year Value (2026): USD 6.49 Billion
• CAGR (2027-2036): 7.21%
• Forecast Year Value (2036): USD 13.02 Billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Fetal Monitoring Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America benefits from advanced maternal healthcare infrastructure, established obstetric practices, strong prenatal-care awareness, and broad access to sophisticated monitoring technologies.
  • Expanding maternal healthcare infrastructure, hospital modernization, rising prenatal-care awareness, and greater focus on maternal and infant safety are supporting adoption.

• Segment Momentum:

  • The non-invasive method held 72.96% of the market in 2025 due to its safety, patient comfort, suitability for continuous monitoring, and improvements in sensor technology, signal accuracy, and portable monitoring systems.
  • Specialty clinics are growing fastest as demand rises for personalized prenatal care, outpatient monitoring, and early risk assessment, supported by wider adoption of advanced fetal monitoring technologies and preventive maternal healthcare.

• Market Expansion Drivers:

  • Rising pregnancy complications driving continuous fetal monitoring adoption in hospitals
  • Increasing preterm births accelerating demand for advanced prenatal monitoring systems
  • Expansion of telehealth-enabled maternal monitoring improving remote pregnancy care access

• Leading Market Participants:

  Top players in the fetal monitoring market include GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Medtronic plc (Ireland), Natus Medical Incorporated (United States), Fujifilm Holdings Corporation (Japan), Becton, Dickinson and Company (United States), Cardinal Health, Inc. (United States), Huntleigh Healthcare Ltd. (United Kingdom), Edan Instruments, Inc. (China)

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 6.49 Billion
  • 2027 Estimated Market Size: USD 6.89 Billion
  • Projected Market Size: USD 13.02 Billion by 2036
  • Growth Forecasts: 7.21% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Non-invasive (Method) | Hospitals (End User) | Ultrasound Devices (Product) | Portable (Portability)
  • Emerging Opportunity Segment: Non-invasive (Method) | Specialty Clinics (End User) | Ultrasound Devices (Product) | Portable (Portability)

Market Growth Drivers and Industry Trends

Rising pregnancy complications driving continuous fetal monitoring adoption in hospitals

Increasing occurrences of pregnancy-related complications are encouraging healthcare providers to adopt advanced monitoring solutions for improved maternal and fetal assessment. The fetal monitoring market growth is driven by rising demand for continuous monitoring systems that help clinicians track fetal health indicators during pregnancy and delivery. Hospitals are increasingly prioritizing technologies that support early identification of potential risks and enable timely medical interventions in critical situations.

Increasing preterm births accelerating demand for advanced prenatal monitoring systems

The growing incidence of premature births is creating greater demand for reliable prenatal monitoring technologies that help manage high-risk pregnancies. The fetal monitoring market will drive adoption as healthcare facilities require advanced systems capable of providing continuous assessment of fetal conditions and supporting specialized neonatal care planning. Enhanced monitoring capabilities are helping medical teams improve decision-making throughout pregnancy management and delivery procedures.

Expansion of telehealth-enabled maternal monitoring improving remote pregnancy care access

The integration of telehealth technologies into maternal care is expanding access to pregnancy monitoring beyond traditional hospital environments. The fetal monitoring market will boost demand as remote monitoring solutions allow healthcare providers to track maternal and fetal health data while supporting patients in geographically distant locations. These systems are improving care continuity by enabling virtual consultations, remote assessments, and better management of pregnancies requiring regular observation.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising pregnancy complications driving continuous fetal monitoring adoption in hospitals	2.2%	High	North America, Asia Pacific	High	Near Term
Increasing preterm births accelerating demand for advanced prenatal monitoring systems	1.9%	High	Europe, Asia Pacific	High	Near Term
Expansion of telehealth-enabled maternal monitoring improving remote pregnancy care access	1.6%	Moderate	North America, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

The fetal monitoring market was led by North America in 2026, reflecting the region's advanced maternal healthcare infrastructure and broad availability of sophisticated obstetric monitoring technologies. High awareness of prenatal care, established clinical practices, and increasing emphasis on maternal and fetal safety support demand for continuous and reliable monitoring during pregnancy and childbirth. Healthcare providers are also adopting advanced monitoring solutions that can facilitate timely identification of fetal distress and support clinical decision-making. Strong healthcare expenditure, access to specialized obstetric services, and ongoing technological improvements in monitoring devices further contribute to the region's established market position.

Asia Pacific is anticipated to be the fastest-growing regional market as healthcare systems expand maternal and neonatal care capabilities and access to obstetric services improves. Increasing awareness of prenatal health, rising healthcare expenditure, and the modernization of hospitals and maternity facilities are creating favorable conditions for fetal monitoring adoption. The growing focus on reducing maternal and infant complications is also encouraging healthcare providers to strengthen pregnancy surveillance and monitoring practices. In addition, expanding access to advanced medical equipment and improving healthcare infrastructure in emerging economies are expected to broaden the use of fetal monitoring technologies across the region.

No card data available for this language/report.

Segment Leadership and Growth Trends

 

Method Segment Analysis: Non-invasive (Largest & Fastest-Growing Segment)

The fetal monitoring market was led by the non-invasive method segment, which accounted for the largest share of 72.96% in 2026 while also emerging as the fastest-growing segment. Its leadership is supported by widespread clinical preference for safer monitoring approaches that minimize risks to both the mother and fetus while enabling continuous assessment throughout pregnancy and labor. Non-invasive techniques are routinely adopted across healthcare settings due to their ease of use, patient comfort, and suitability for repeated examinations. Ongoing improvements in sensor technologies, signal accuracy, and portable monitoring systems are further strengthening the adoption of non-invasive fetal monitoring, reinforcing its position as the preferred method for prenatal and intrapartum care.

End User Segment Analysis: Hospitals (Largest Segment) vs Specialty Clinics (Fastest-Growing Segment)

Holding the largest share of the fetal monitoring market, the hospitals segment accounted for 56.39% in 2026. Hospitals remain the primary setting for fetal monitoring owing to their comprehensive obstetric services, availability of advanced diagnostic equipment, and capability to manage both routine and high-risk pregnancies. The presence of multidisciplinary care teams and continuous monitoring facilities further supports the dominance of hospitals, particularly for labor and delivery management where immediate medical intervention may be required.

The specialty clinics segment is emerging as the fastest-growing end-user category due to the increasing demand for personalized prenatal care and improved accessibility to specialized maternal health services. These clinics are expanding their adoption of advanced fetal monitoring technologies to provide timely risk assessment, regular pregnancy evaluations, and early detection of fetal complications. Growing awareness of preventive maternal healthcare and the preference for outpatient monitoring services continue to strengthen the role of specialty clinics in the evolving healthcare landscape.

Product Segment Analysis: Ultrasound Devices (Largest & Fastest-Growing Segment)

In the fetal monitoring market, ultrasound devices held the largest share of 54.8% in 2026 and also represented the fastest-growing product segment. Their strong position is driven by their essential role in assessing fetal growth, anatomical development, placental health, and overall pregnancy progression without exposing patients to invasive procedures. Continuous advancements in imaging quality, portability, and diagnostic capabilities have enhanced clinical confidence and expanded their use across prenatal care settings. Increasing emphasis on early diagnosis, routine pregnancy screening, and improved maternal-fetal outcomes continues to reinforce the sustained demand for ultrasound devices.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Method	Invasive, Non-invasive	Non-invasive	Non-invasive
End User	Hospitals, Specialty Clinics, Others	Hospitals	Specialty Clinics
Product	Ultrasound Devices, Electronic Fetal Monitoring (EFM), Uterine Contraction Monitor, Accessories and Consumables, Others	Ultrasound Devices	Ultrasound Devices
Portability	Portable, Non-portable	Portable	Portable

Competitive Landscape and Market Positioning

Top players in the fetal monitoring market:

1. GE HealthCare Technologies, Inc. (United States)
2. Koninklijke Philips N.V. (Netherlands)
3. Siemens Healthineers AG (Germany)
4. Medtronic plc (Ireland)
5. Natus Medical Incorporated (United States)
6. Fujifilm Holdings Corporation (Japan)
7. Becton Dickinson and Company (United States)
8. Cardinal Health, Inc. (United States)
9. Huntleigh Healthcare Ltd. (United Kingdom)
10. Edan Instruments, Inc. (China)

Clinical expectations for earlier risk identification and improved maternal care are driving suppliers to compete through technological refinement rather than conventional product expansion. Greater emphasis is being placed on enhancing monitoring accuracy, improving patient comfort, and integrating diagnostic information into connected healthcare environments that support clinical decision-making. Competition is also extending into software capabilities, interoperability, and workflow efficiency as healthcare providers prioritize systems that fit seamlessly into existing care pathways. Providers with strong expertise in regulatory compliance, product reliability, and ongoing clinical support are increasingly positioned to secure long-term adoption across both hospital and outpatient settings.

Industry Development/News

Company Name	Date	Key Development
Maimonides Medical Center	Jun-26	Maimonides Medical Center raised over USD 350,000 via its annual Golf Classic to fund comprehensive upgrades for fetal monitoring systems across its active labor and delivery units, expanding internal maternal and fetal care infrastructure.
Oli	May-26	Oli secured AUD 6.5 million in funding to accelerate clinical trials for its labor monitoring device in Australia and the United States. The investment prepares the company for upcoming regulatory submissions and subsequent commercialization phases.
Wavelet Medical	Apr-26	Wavelet Medical secured USD 7 million in seed funding and formed a co-creation alliance with Aegis Ventures. The capital and partnership aim to accelerate the development and clinical adoption of the company's proprietary AI-powered, non-invasive fetal brain monitoring platform.
University of Maryland Medical System (UMMS)	Jan-25	UMMS established the Virtual NEST, an AI-supported remote fetal monitoring center providing continuous, real-time clinical oversight across its network of labor and delivery units. The initiative represents a significant step forward in centralized maternal care infrastructure and operations.
PeriGen	Jan-25	PeriGen partnered with Texas Children's Hospital and Malawi's Ministry of Health to deploy AI-powered fetal monitoring software at a rural hospital facility. The collaboration demonstrates the operational viability and clinical efficacy of advanced monitoring platforms in resource-constrained environments.
GE HealthCare	Oct-24	GE HealthCare launched the Versana Premier AI ultrasound system, integrating advanced AI-enabled imaging capabilities into its medical portfolio. The system expands clinical options for detailed obstetric and prenatal examinations, specifically enhancing routine fetal assessment workflows.
GE HealthCare	Feb-24	GE HealthCare secured U.S. FDA 510(k) clearance for its Novii+ Wireless Patch Solution, a non-invasive maternal and fetal monitoring system. The approval enables real-time tracking of uterine activity and heart rates during antepartum and intrapartum periods, strengthening its clinical utility.
Neoventa Medical	Jun-23	Neoventa Medical entered a strategic distribution partnership with YMS to supply advanced fetal monitoring solutions to healthcare providers in South Africa. The agreement expands Neoventa's geographic reach and strengthens its commercial distribution network within the regional market.